http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101288698-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 2006-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101288698-B1
titleOfInvention N- (heteroaryl) -lH-indole-2-carboxamide derivatives and their use as vanilloid TRP1 receptor ligands
abstract The present invention relates to compounds of formula (I)n n n <Formula I>n n n n n n n n Wheren n n n is 0, 1, 2 or 3;n n n X 1 , X 2 , X 3 , X 4 , Z 1 , Z 2 , Z 3 , Z 4 and Z 5 represent a hydrogen atom or a specific specific substituent;n n n W represents a fused bicyclic group of formula (a) linked to a nitrogen atom at position 1, 2, 3 or 4,n n n <Formula a>n n n n n n n n A represents a 5- to 7-membered heterocycle comprising 1 to 3 heteroatoms selected from O, S and N.n n n The compound is a ligand of the TRPV 1 vanilloid receptor useful for treating pain and inflammation.n n n TRPV1 vanilloid receptor, pain, inflammation
priorityDate 2005-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03044014-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03068749-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004072069-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004056768-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466722093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457185475

Total number of triples: 39.